ARS Pharmaceuticals Inc (SPRY): Total Asset Value of Company

Graphic logo of ARS Pharma (SPRY)

ARS Pharmaceuticals (SPRY) is implementing high-precision automated filling systems at partner sites, eliminating human error during sterile packaging. The compact spray format optimizes medication transport, reducing costs for delivery to pharmacies. Market price action on GURU.Markets shows total assets at 281.50, confirming the development of an emergency care ecosystem featuring unique needle-free technologies and a protected patent portfolio.

ARS Pharmaceuticals (SPRY) Company Total Assets: for the period 04/28/2023 - 10/28/2026

Comprehensive metric breakdowns and analytics for ARS Pharma (SPRY)

- price and consensus price forecast:
Market Price ars-pharma.com|SPRY - Price Target Chart
- market capitalization data:
Market Valuation ARS Corp|SPRY - Enterprise Value
- book capitalization data:
Accounting Value of a Share ARS Pharmaceuticals|SPRY - Book Capitalization|Market Capitalization to Book Value Ratio ars-pharma.com|SPRY - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio ARS Pharmaceuticals|SPRY - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio ARS Corp|SPRY - Company Aggregate Debts|Debts to Book Capitalization ARS Corp|SPRY - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings ARS Pharmaceuticals
Fundamental valuation:SPRY, ars-pharma.com
Finished products of ARS Pharmaceuticals

Total assets reflect the aggregate value of business resources, calculated reverse-engineered via ROA to monitor capital efficiency and the risks of balance sheet inflation. By analyzing the assets of ARS Pharmaceuticals (SPRY) through ROA, an investor assesses the financial stability of ARS Pharmaceuticals during the implementation of an innovative nasal spray, which replaces injections and generates stable long-term demand for the drug.

Competitors of ARS Pharmaceuticals (SPRY)

HLN (haleon.com) - Company Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value TBPH (Theravance Biopharma Inc)|AQST: Aggregate Company Assets|SCPH - Company Assets|Cumulative Company Assets Tectonic TECX|TNXP - Aggregate Business Assets|Company Total Assets sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Aggregate Asset Value|Company Total Assets BHST (BioHarvest)|Company Assets EXOZ|Oramed Pharmaceuticals (ORMP) - Aggregate Company Assets|Aggregate Asset Value enterabio.com (ENTX)|Company Total Assets HYFT (MindWalk Holdings Inc.)|ABVC BioPharma Inc. - Company Total Assets|Aggregate Company Assets Cumberland Pharma (CPIX)|QNTM: Aggregate Asset Value|FibroGen, Inc. - Aggregate Company Assets|Company Total Asset Base telomirpharma.com|RANI - Cumulative Company Assets|Aggregate Asset Value SNYR|RLYB - Aggregate Company Assets|Total Asset Value of Company lexariabioscience.com (LEXX)|Company Total Assets Pulmatrix, Inc.|Aggregate Asset Value Pheton Holdings Limited PTHL|Aptorum - Company Total Assets|LYRA: Company Total Assets|Aggregate Company Assets Impact BioMedical IBO|TNFA (TNF Pharmaceuticals, Inc.) - Aggregate Asset Value|Aggregate Company Assets YCBD|Cumulative Company Assets painreform.com|Company Total Assets CYTO|Company Total Assets Lipella Pharmaceuticals Inc (LIPO)|Optinose - Company Total Assets|Cumulative Company Assets Pieris Pharma PIRS|PROC (Procaps Group S.A.) - Company Total Assets|petrospharma.com (PTPI) - Company Assets|QLI: Cumulative Company Assets|Company Total Assets Acelyrin Inc.|TFF Pharma (TFFP) - Cumulative Company Assets